Related Experiment Video
Updated: Jul 10, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation
Haowei Wang1, Huijie Zhang1, Lin Miao1
1Department of Forensic Medicine, School of Forensic Medicine, Kunming Medical University, Kunming, China.
Abstract:
Mushroom poisoning, predominantly caused by α-amanitin, is a critical food safety concern in worldwide, with severe cases leading to hepatotoxicity and fatalities. This study delves into the hepatotoxic effects of α-amanitin, focusing on the NLRP3 inflammasome and PPAR-γ's regulatory role in inflammation. In vitro studies with L-02 cells showed that α-amanitin reduces cell viability and triggers NLRP3 inflammasome activation, increasing NF-κB phosphorylation and pro-inflammatory cytokines IL-18 and IL-1β. The NLRP3 inhibitor MCC950 mitigated these effects without impacting NF-κB. Conversely, PPAR-γ knockdown intensified the inflammatory response. In vivo, α-amanitin induced dose-dependent liver injury in mice, evident by elevated serum ALT and AST, and histological liver damage. MCC950 pretreatment offered protection against hepatotoxicity, while PPAR-γ inhibition with GW9662 worsened the condition. The study highlights the interplay between α-amanitin, NLRP3, and PPAR-γ in hepatotoxicity, proposing potential therapeutic targets for mushroom poisoning-induced liver diseases.
Insights
Mushroom poisoning from α-amanitin causes liver damage by activating the NLRP3 inflammasome. Inhibiting NLRP3 or boosting PPAR-γ may protect against this severe hepatotoxicity.
Area of Science:
- Toxicology
- Hepatology
- Immunology
Background:
- Mushroom poisoning, often caused by α-amanitin, is a significant global health issue.
- Severe cases result in liver damage (hepatotoxicity) and can be fatal.
- Understanding the molecular mechanisms of α-amanitin-induced liver injury is crucial for developing treatments.
Purpose of the Study:
- To investigate the role of the NLRP3 inflammasome and PPAR-γ in α-amanitin-induced hepatotoxicity.
- To explore potential therapeutic strategies targeting these pathways.
Main Methods:
- In vitro studies using L-02 cells to assess cell viability and inflammatory markers.
- In vivo studies using a mouse model to evaluate liver injury and treatment effects.
- Pharmacological inhibition of NLRP3 (MCC950) and PPAR-γ (GW9662) was employed.
Main Results:
- α-amanitin reduced cell viability and activated the NLRP3 inflammasome, increasing IL-18 and IL-1β production.
- NLRP3 inhibition (MCC950) protected cells and mice from α-amanitin-induced liver injury.
- PPAR-γ knockdown or inhibition exacerbated liver damage, indicating a protective role.
Conclusions:
- α-amanitin induces hepatotoxicity via NLRP3 inflammasome activation.
- PPAR-γ plays a protective role in mitigating α-amanitin-induced liver inflammation.
- Targeting the NLRP3 inflammasome and modulating PPAR-γ activity represent potential therapeutic avenues for mushroom poisoning.
More Related Videos
Related Concept Videos
Physical Properties of Amines
Drug Toxicity: Dose-Dependent Reactions
Inhalation Anthrax
Amebiasis
Antifungal Agents
Hepatic Encephalopathy

